Interviews

Marcus D. Wilson, PharmD, President, HealthCore, states that there is variability within and between different organizations that utilize comparative effectiveness research.

Aaron S. Kesselheim, MD, JD, MPH, Assistant Professor of Medicine, Harvard Medical School; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, explains that academic detailing is the best way to deliver evidence-based information to various parties.

Joshua D. Lenchus, DO, RPh, FACP, FHM, discusses the lack of impact comparative effectiveness research (CER) has had on patient safety. In addition, he speaks about the need for more comparisons that study safety and efficacy in patient populations.